SCOPE SUMMIT
Outcome Health enters clinical trial space with patient recruitment solution
Outcome Health is looking to solve the “age-old” issue of patient recruitment in an industry that it says was “ripe for disruption.”
Archives for January 31, 2017
Italy bans antibiotic APIs made by Antibioticos do Brasil
Italy has banned APIs made by Antibioticos do Brasil LTDA (ABL) at its facility in Bairro Itapavussu, Sao Paulo over sterility concerns.
Novartis unit Lek to expand Slovenian antibiotics plant
Sandoz subsidiary Lek will expand production capacity at its antibiotics facility in Prevalje, Slovenia.
Shredded records and unofficial spreadsheets land Italian plant with FDA warning
Data integrity issues have landed Italian drugmaker FACTA Farmaceutici with a US FDA warning letter.
Novartis oncology drug bolsters revenue with another EU approval
The European Commission has approved oral formulation of Novartis' seizure treatment Everolimus under the trade name Votubia.
Parexel looks to 'bridge gap' to compassionate use studies as demand surges
Parexel’s expanded Managed Access Program helps biopharmaceutical companies provide compassionate access to patients as the industry faces an increasing public demand for treatment options.